InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the complete record of transactions filed by Kronenfeld Mark A., Director. Insider active across 1 company, notably Pacira BioSciences, Inc.. Cumulatively, 7 disclosures have been recorded. Activity tracked since 9 June 2021. The latest transaction was disclosed on 11 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Kronenfeld Mark A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
6,163 shares0Common StockSEC:0001628280-26-019892:0
9,999 shares0Common StockSEC:0001396814-25-000087:0
5,230 shares0Common StockSEC:0001396814-24-000072:0
1,775 shares0Common StockSEC:0001209191-23-038024:0
15,000 shares@ US$29.90100.0% of flowCommon StockSEC:0001209191-23-036270:0
1,160 shares0Common StockSEC:0001209191-22-035224:0
1,066 shares0Common StockSEC:0001209191-21-040085:0
7 of 7 declarations
About Kronenfeld Mark A.
Mark A. Kronenfeld is a Director at Pacira BioSciences, Inc., a biopharmaceutical company focused on developing therapeutic solutions. As a board member, he contributes to the company's strategy and oversight of its operations, ensuring that shareholder interests are protected.
